Stockreport

Alimera Acquires U.S. Commercial Rights to YUTIQ®

Alimera Sciences, Inc.  (ALIM) 
Last alimera sciences, inc. earnings: 4/29 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alimerasciences.com/investor-relations
PDF Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023 Alimera projects at least $100 million of consolidated net revenue and over $20 million of Ad [Read more]